Regenerative Therapy in Osteoarthritis
Regenerative Therapy in Osteoarthritis
Osteoarthritis( OA) is the most common common disorder in the world. It generally affects the knee & elbow and current treatment options are limited and substantially focusing on symptom relief. It's now known that Osteoarthritis is the result of both biological and mechanical events that disrupt catabolic and anabolic processes in the joints. lately, exploration in regenerative therapeutics has been gaining further interest of its eventuality to restore the normal structure and functions of the following towel injury. The use of Mesenchymal Stem cells in knee Osteoarthritis seems promising as it's suitable to separate into a wide variety of cells, similar as myocytes, tendocytes and ligament cells. The thing is to use the body’s own form mechanisms in order to heal the tissues that were preliminarily irrecoverable. The available exploration on similar therapies, similar as mesenchymal stem cells, platelet rich tube, hyaluronic acid, and prolotherapy, further exploration is demanded to establish the use of these therapies for the treatment of knee OA.
Related Conference of Regenerative Therapy in Osteoarthritis
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
19th International Conference on Human Genomics and Genomic Medicine
Regenerative Therapy in Osteoarthritis Conference Speakers
Recommended Sessions
- 3D Bio-Printing and Organ Printing
- Advances in Stem Cells and their Niches
- Bio Banking
- Biomaterials and Biomedical Applications
- Bone Marrow Transplantation
- Cancer Stem Cell and Oncology
- Cell and Gene Therapy
- Cell Biology
- Cell Therapy for Cardiovascular and Neurological Disorders
- COVID-19 and Convalescent Plasma
- Dental Stem Cell
- Effect of Aging on Stem Cells
- Novel Stem Cell Techniques
- Regenerative Medicine research and development
- Regenerative Therapy in Osteoarthritis
- Stem Cell in Drug Discovery
- Stem Cells
- Stem Cells and Disease Modelling
- Stem Cells and Veterinary Applications
- Tissue Engineering
- Translational Research in Stem Cell Assessments
Related Journals
Are you interested in
- Adult Stem Cells and Tissue-Specific Regeneration - Regenerative Medicine_2026 (France)
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cardiovascular Regeneration and Stem Cell Therapeutics - Regenerative Medicine_2026 (France)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Embryonic Stem Cells and Pluripotent Stem Cells - Regenerative Medicine_2026 (France)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Hematopoietic Stem Cell Transplantation - Regenerative Medicine_2026 (France)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) - Regenerative Medicine_2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications - Regenerative Medicine_2026 (France)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Orthopedic Regenerative Medicine and Bone Tissue Engineering - Regenerative Medicine_2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regenerative Medicine: Current Advances and Future Perspectives - Regenerative Medicine_2026 (France)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Regenerative Medicine_2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cell Therapy for Neurological Disorders - Regenerative Medicine_2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
